Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Red Biotechnology Market: By Application: Biopharmaceutical Production, Gene Therapy, Pharmacogenomics, Genetic Testing; By End Use: Pharmaceutical Industry, CMO & CRO, Research Institutes; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Red Biotechnology Market Outlook

The global red biotechnology market attained USD 320 billion in 2020 and is expected to grow at a CAGR of 6% during the forecast period of 2022-2027 to reach a value of USD 454 billion by 2026.

 

Global Red Biotechnology Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

It is anticipated that the increasing awareness of chronic illness therapy and a strong pipeline of fresh therapeutic molecules will drive the global red biotechnology market.

 

Market Segmentation

Red biotechnology is a bio-pharmaceutical that involves the utilization of organisms to enhance health care and aid the body in fighting diseases.

 

Global Red Biotechnology Market By Application

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The global red biotechnology market is segmented into applications and end-uses.

Based on applications, the red biotechnology market can be segmented as:

  • Biopharmaceutical Production
  • Gene Therapy
  • Pharmacogenomics
  • Genetic Testing

Based on end-uses, the red biotechnology market can be divided as:

  • Pharmaceutical Industry
  • CMO and CRO 
  • Research Institutes
  • Others

The EMR report looks into the regional red biotechnology markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Red Biotechnology Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

Owing to the increasing demand for gene therapy, clinical research, and trials, the industry for red biotechnology is increasing. People have begun to preserve their stem cells at the moment of birth because of growing awareness, and red biotechnology makes an enormous profit in this segment. The red biotechnology market is aided by the growth of pharmaceutical companies. With the increasing number of patients suffering from cancer globally, red biotechnology applications are becoming common as it helps to understand the cause of the disease, thus, further aiding the growth of the red biotechnology market. The industry is being fuelled by the increased financing in the healthcare industry.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global red biotechnology industry, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Pfizer Inc. (NYSE: PFE)
  • Biogen Inc. 
  • Amgen Inc. 
  • AstraZeneca Plc. 
  • Gilead Sciences, Inc. 
  • F. Hoffmann-La Roche, Ltd. 
  • Merck KGaA 
  • Bristol-Myers Squibb Company
  • Regeneron Pharmaceuticals Inc.
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Application, End Use, Region
Breakup by Application Biopharmaceutical Production, Gene Therapy, Pharmacogenomics, Genetic Testing
Breakup by End Use Pharmaceutical Industry, CMO & CRO, Research Institutes, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Pfizer Inc. (NYSE: PFE), Biogen Inc. (NASDAQ: BIIB), Amgen Inc. (NASDAQ: AMGN),
AstraZeneca Plc. (LON: AZN), Gilead Sciences, Inc. (NASDAQ: GILD), F. Hoffmann-La Roche, Ltd. (SWX: ROG), Merck KGaA (ETR: MRK), Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface  
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Red Biotechnology Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Red Biotechnology Historical Market (2017-2021) 
    8.3    Global Red Biotechnology Market Forecast (2022-2027)
    8.4    Global Red Biotechnology Market by Application
        8.4.1    Biopharmaceutical Production
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Gene Therapy
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Pharmacogenomics
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Genetic Testing
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
    8.5    Global Red Biotechnology Market by End-use 
        8.5.1    Pharmaceutical Industry
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    CMO & CRO
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Research Institutes
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Others
    8.6    Global Red Biotechnology Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis   
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Pfizer Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Biogen Inc.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3     Amgen Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Astrazeneca Plc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Gilead Sciences, Inc.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    F. Hoffmann-La Roche, Ltd.
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Merck KGaA  
            12.2.7.1    Company Overview
            12.2.7.2    Product Portfolio
            12.2.7.3    Demographic Reach and Achievements
            12.2.7.4    Certifications
        12.2.8    Bristol-Myers Squibb Company
            12.2.8.1    Company Overview
            12.2.8.2    Product Portfolio
            12.2.8.3    Demographic Reach and Achievements
            12.2.8.4    Certifications
        12.2.9    Regeneron Pharmaceuticals Inc.
            12.2.9.1    Company Overview
            12.2.9.2    Product Portfolio
            12.2.9.3    Demographic Reach and Achievements
            12.2.9.4    Certifications
        12.2.10    Others 
13    Industry Events and Developments


List of Key Figures and Tables

1.    Global Red Biotechnology Market: Key Industry Highlights, 2016 and 2026
2.    Global Red Biotechnology Historical Market: Breakup by Application (USD Million), 2017-2021
3.    Global Red Biotechnology Market Forecast: Breakup by Application (USD Million), 2022-2027
4.    Global Red Biotechnology Historical Market: Breakup by End-use (USD Million), 2017-2021
5.    Global Red Biotechnology Market Forecast: Breakup by End-use (USD Million), 2022-2027
6.    Global Red Biotechnology Historical Market: Breakup by Region (USD Million), 2017-2021
7.    Global Red Biotechnology Market Forecast: Breakup by Region (USD Million), 2022-2027
8.    North America Red Biotechnology Historical Market: Breakup by Country (USD Million), 2017-2021
9.    North America Red Biotechnology Market Forecast: Breakup by Country (USD Million), 2022-2027
10.    Europe Red Biotechnology Historical Market: Breakup by Country (USD Million), 2017-2021
11.    Europe Red Biotechnology Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Asia Pacific Red Biotechnology Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Asia Pacific Red Biotechnology Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Latin America Red Biotechnology Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Latin America Red Biotechnology Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Middle East and Africa Red Biotechnology Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Middle East and Africa Red Biotechnology Market Forecast: Breakup by Country (USD Million), 2022-2027   
18.    Global Red Biotechnology Market Structure

Key Questions Answered in the Report

In 2020, the global red biotechnology market attained a value of nearly USD 320 billion.

The market is projected to grow at a CAGR of 6% between 2022 and 2027.

The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 454 billion by 2026.

The major drivers of the industry, such as the increasing awareness of chronic illness therapy and a strong pipeline of fresh therapeutic molecules, are expected to aid the market growth.

The key market trend guiding the industry growth include the rising investments into the healthcare industry.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Biopharmaceutical production, gene therapy, pharmacogenomics, and genetic testing are the leading application segments of the product in the industry.

Pharmaceutical industry, CMO and CRO, and research institutes, among others, are the significant end-uses of the product in the market.

The major players in the industry are Pfizer Inc., Biogen Inc., Amgen Inc., AstraZeneca Plc., Gilead Sciences, Inc., F. Hoffmann-La Roche, Ltd., and Merck KGaA, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals Inc., among others.

Analyst Review

The global red biotechnology market attained a value of USD 320 billion in 2020, driven by the increasing awareness of chronic illness therapy. Aided by the strong pipeline of fresh therapeutic molecules, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 6%. The market is projected to reach USD 454 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on applications, the red biotechnology industry can be segmented into biopharmaceutical production, gene therapy, pharmacogenomics, and genetic testing. On the basis of end-use, the industry is divided into pharmaceutical industry, CMO and CRO, research institutes, and others. The major regional markets for red biotechnology are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Pfizer Inc., Biogen Inc., Amgen Inc., AstraZeneca Plc., Gilead Sciences, Inc., F. Hoffmann-La Roche, Ltd., and Merck KGaA, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER